Condensed Consolidated Statements of Cash Flows (USD $) In Thousands, unless otherwise specified	9 Months Ended
	Mar. 31, 2014	Mar. 31, 2013
Cash flows from operating activities:
Net (loss) income	$ (41,079)	$ 6,489
Adjustments to reconcile net (loss) income to net cash provided by operating activities:
Depreciation	7,767	3,389
Amortization of intangible assets	18,937	1,168
Provision for (recovery of) doubtful accounts	898	(556)
Stock-based compensation	9,874	5,625
Loss (gain) on disposition of long lived assets, net	922	(11,451)
Other non-cash charges	1,345	1,284
Changes in operating assets and liabilities, net
Accounts receivable	(24,171)	(1,889)
Inventories	(13,313)	10,952
Prepaid expenses and other assets	(1,354)	1,363
Accounts payable	(5,404)	(9,101)
Accrued compensation and benefits	(1,764)	(2,526)
Restructuring liabilities	(929)	1,311
Deferred revenue	17,625	(708)
Other current and long term liabilities	29	1,653
Net cash (used in) provided by operating activities	(30,617)	7,003
Cash flows from investing activities:
Capital expenditures	(17,384)	(4,422)
Acquisition, net of cash acquired	(180,000)	0
Purchases of investments	(9,045)	(40,113)
Proceeds from maturities of investments and marketable securities	26,722	13,867
Proceeds from sales of investments and marketable securities	56,594	12,478
Purchases of intangible assets	0	(335)
Proceeds from sales of facilities	0	42,659
Net cash (used in) provided by investing activities	(123,113)	24,134
Cash flows from financing activities:
Borrowings under Revolving Facility	59,000	0
Borrowings under Term Loan	65,000	0
Repayment of Term Loan	(1,625)	0
Proceeds from issuance of common stock	6,296	2,539
Repurchase of common stock	0	(10,973)
Net cash provided by (used in) financing activities	128,671	(8,434)
Foreign currency effect on cash	611	293
Net (decrease) increase in cash and cash equivalents	(24,448)	22,996
Cash and cash equivalents at beginning of period	95,803	54,596
Cash and cash equivalents at end of period	$ 71,355	$ 77,592